HEALTH TECHNOLOGY

nference Launches AI-Driven Platform and Expands Partnership with Mayo Clinic, Offering Access to One of the Deepest Real-World

nference | September 22, 2022 | Read time : 02:00 min

nference Launches

nference, a science-first software company transforming healthcare by making biomedical data computable announced the launch of its AI-driven nSights platform, which will allow biopharma, medical device companies, and diagnostic firms to access and directly engage with curated, de-identified healthcare data to advance research and discovery.

The company also expanded its exclusive 12-year strategic relationship with Mayo Clinic, providing nference partners and customers with access to Mayo Clinic Platform’s extensive de-identified electronic health data across a range of disease and therapeutic areas. This expanded collaboration will increase access to data-derived insights and knowledge by establishing a Mayo Clinic-branded version of nSights, called Mayo Clinic Platform_Discover, built and supported by nference to help its partners solve some of the most complex clinical challenges.

nSights is a software platform that makes real-world data available across multiple data modalities (clinical, molecular, and imaging). The platform enables data exploration, hypothesis generation, analytics, and data science capabilities, including algorithm development, for users of all backgrounds. nSights provides a longitudinal, 360-degree view of each patient by leveraging an ensemble of biomedical information, such as electronic health records, electrocardiograms, radiology images and more. Future iterations will also include digital pathology and genomics. The platform is supported by a flexible data dictionary, allowing for the generation of new patient-level features for analysis.

The potential of electronic health data remains locked at medical centers and is frequently under-leveraged due to data complexity, privacy, and security concerns. Our expanded collaboration with Mayo Clinic Platform provides the framework for nference’s deployment of nSights and enables our customers to access de-identified ‘patient-level’ data to drive research and development of new therapeutics. I look forward to continuing to build and fortify our partnership with the Mayo Clinic team as we work together to improve healthcare through data-derived insights and knowledge.”

Mike Koenig, chief commercial officer at nference

As a result of the company’s partnerships with major academic medical centers like Mayo Clinic, nSights provides access to the deepest curated patient-level dataset available across all therapeutic areas, including cardiology, oncology, metabolic diseases, immunology, and infectious diseases. The platform offers insights from both structured and unstructured records, representing more than 20 years of longitudinality, including data from over 520 million clinical notes, 1.3 billion lab test results, 10.2 billion flowsheets, and more.

“Over the past year, our collaboration with nference, leveraging nSights, has accelerated clinical decision support and care in significant ways," said Maneesh Goyal, chief operating officer, Mayo Clinic Platform. "Data-derived insights and knowledge help us accelerate and enhance innovation and meet the unmet needs of patients everywhere.”

About nference
Through its powerful technology platform and software, nference is transforming health care by making biomedical knowledge computable. Its partnership with Mayo Clinic has given nference an opportunity to synthesize decades of institutional knowledge, producing real-world evidence in real-time by converting large amounts of de-identified data into deep insights to advance discovery and development of diagnostics and therapeutics. Its proprietary AI-enabled software platform, nSights, has been used to accelerate life sciences research, development, and clinical care in significant ways, including biomarker discovery and validation, real-world evidence generation leveraging real-world data, early disease detection, public health policy generation and validation, and more. nference is headquartered in Cambridge, Mass. 
 

Spotlight

Santa Clara Valley Medical Center is a 574-bed tertiary medical center, owned and operated by the County of Santa Clara. The Medical Center is part of the Santa Clara Valley Health and Hospital System.

Spotlight

Santa Clara Valley Medical Center is a 574-bed tertiary medical center, owned and operated by the County of Santa Clara. The Medical Center is part of the Santa Clara Valley Health and Hospital System.

Related News

HEALTH TECHNOLOGY

Stryker Launches Q Guidance System with Spine Guidance Software

Stryker | September 28, 2022

Stryker one of the world’s leading medical technology companies, announced the launch of its Q Guidance System for spine applications. The System combines new optical tracking options provided by a redesigned, state-of-the-art camera with sophisticated algorithms of the newly launched Spine Guidance Software to deliver more surgical planning and navigation capability than ever before. When used with the Q Guidance System, the Spine Guidance Software is intended as a planning and intraoperative guidance system to enable open or percutaneous computer-assisted surgery and is the first spine navigation software to receive FDA clearance for use with pediatric patients aged 13 and older. “The Q Guidance System offers cutting-edge tracking options with its 4th generation FP8000 camera, and Spine Guidance Software allows for advanced planning and computer-assisted execution. With the addition of the Q Guidance System, customers now have access to a robust solution that includes imaging, guidance, and instruments and is fully integrated and designed to meet complex customer needs. In the years to come, our goal is to use the versatility of this System to help advance our technologies across multiple specialties including cranial, spine, ENT, and orthopaedics.” Robbie Robinson, President of the Spine division Q Guidance offers surgeons numerous benefits, including A proprietary camera: The Q Guidance System features a 4th generation FP8000 camera that offers unmatched speeds and the flexibility of multiple optical tracking methods, including full-spectrum active/passive hybrid optical tracking.1 It is the only guidance system with proprietary active technology and a non-invasive patient tracker, SpineMask. Image processing: Spine Guidance Software features completely redesigned applications, semi-automatic and automatic processing features, gesture recognition, and broad compatibility with various types of image sets. Spine Guidance Software: Spine Guidance Software is designed to help surgeons optimize their workflow, minimize their time in the OR and address complex clinical decisions and techniques intraoperatively. Its computational power is designed to support our spine product and software roadmap. It is our intention to develop and release new technologies within the Q ecosystem. “In my experience, Spine Guidance Software truly simplifies preoperative planning, navigation and execution,” said Stephen George, M.D., Director of Spine Surgery, Nicklaus Children's Hospital. “From what I have seen, the Q Guidance System is a powerful platform that has provided reliability and performance in a solution that is conveniently scalable to a wide array of surgical procedures, ranging from a single level fusion to a multi-level deformity correction. When used with the Airo TruCT scanner, Spine Guidance Software is designed to minimize time spent intraoperatively planning, thanks to its auto segmentation capability, while also allowing us the benefit of being able to image the patient in the surgical position. Its intuitive and customizable software enables us to configure the System to fit our preferences.” Stryker will be featuring the Q Guidance System and offering demonstrations at several upcoming meetings, including Society for Minimally Invasive Spine Surgery (SMISS) 2022 Annual Forum in Las Vegas, Sept. 29–Oct. 1, 2022 Congress of Neurological Surgeons (CNS) 2022 Annual Meeting in San Francisco, Oct. 8–12, 2022 North American Spine Society (NASS) Annual Meeting in Chicago, Oct. 12–15, 2022 About Stryker Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, and Orthopaedics and Spine that help improve patient and hospital outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually.

Read More

HEALTH TECHNOLOGY

Inbound Health Launches to Enable Partners to Build and Scale Hospital and Skilled Nursing Facility-at-Home Care Models

Allina Health and Flare Capital Partners | October 19, 2022

Allina Health and Flare Capital Partners announced the launch of Inbound Health, a new company that enables health systems and health plans to offer hospital-at-home and skilled nursing-at-home programs. These innovative new care models create the ability to care for patients requiring facility-level acute or post-acute care in their home, thereby improving patient access, satisfaction, and outcomes while lowering total cost of care. Inbound Health provides the full stack of capabilities that are required to scale at-home care models including home-based care pathways, virtual care teams, engagement and workflow technology, analytics, supply chain partnerships, operational oversight and payment models. The company's flexible partnership structure enables customers to leverage their existing assets and capabilities while relying on Inbound Health to fill the gaps required to scale these programs across their service area To date, more than 4,200 patients across 185 primary diagnoses have been cared for through the Inbound Health platform, which has been operational in Allina Health’s service area since May 2020. The program has allowed Allina Health to manage a wider swath of the continuum of care for its patients, thereby ensuring that care is delivered in a safe, coordinated and patient-centric manner. The company combines biometric monitoring, digital surveillance, in-home nursing and therapy, virtual visits with hospitalists and geriatricians, and a comprehensive supply chain to deliver a safe and high-quality care program. Inbound Health has proven that the program lowers total-cost-of-care by 30-40% on a risk-adjusted basis while achieving similar or improved clinical outcomes when compared to traditional facility-based care. These outcomes have enabled Inbound Health and Allina to develop unique episodic-based payer contracts with multiple Commercial and Medicare Advantage payers in Minnesota, a payment model that the company plans on replicating with partners in other markets. “The home hospital programs that we’ve scaled to thousands of patients here in Minnesota are rooted in our Population Health drivers of delivering safe, high quality, affordable care that’s timely and convenient to access. We are excited for Inbound Health to leverage the capabilities and know-how that power these programs to scale similar at-home programs across the nation.” Lisa Shannon, President and CEO of Allina Health Inbound Health will be led by CEO Dave Kerwar who brings a 20-year track record of executing leading-edge strategies to improve care quality, reduce cost, and create consumer-centricity in healthcare. Previously, Dave was the Chief Product Officer at Mount Sinai Health System where he built innovative technology-enabled operations to scale direct-to-consumer, direct-to-employer, and population health programs. Prior to Mount Sinai, Dave led business development for Aetna’s Joint Ventures where he launched Provider Owned Health Plans with leading health systems across the country. “We are proud to be backed by one of the most prestigious health systems and one of the largest dedicated healthcare technology venture capital firms in the country in our pursuit to revolutionize this new level of care,” said Dave Kerwar. “Inbound Health will leverage the clinical, operational, and technology assets that we’ve developed alongside Allina Health to enable our customers nationwide to safely offer facility-level care in the home, at a lower cost and with an elevated patient and caregiver experience.” Inbound Health will use the new financing to continue to advance its proprietary technology platform that integrates with a variety of biometric monitoring devices and brings forward engagement, workflow, and AI-powered analytic capabilities that are purpose-built to scale these at-home care programs. This platform optimizes Inbound Health’s ability to perform key functions on behalf of its partners, including: “Home-based acute care models represent a compelling opportunity to lower the cost of care while increasing access and satisfaction for patients,” said Michael Greeley, Co-founder and General Partner, Flare Capital Partners. “Inbound Health is truly differentiated, not only due to the unique clinical and technology assets that underpin the platform, but also because it has powered one of the largest hospitals and SNF-at-home programs in the country. We look forward to partnering with Dave and the Inbound Health team to scale this platform nationally.” About Allina Health Allina Health is dedicated to the prevention and treatment of illness and enhancing the greater health of individuals, families and communities throughout Minnesota and western Wisconsin. A not-for-profit health care system, Allina Health cares for patients from beginning to end-of-life through its 90+ clinics, 12 hospitals, 14 retail pharmacies, specialty care centers and specialty medical services that provide home care, senior transitions, hospice care, home oxygen and medical equipment, and emergency medical transportation services. About Flare Capital Partners Flare Capital Partners strives to help build significant healthcare technology, digital health, and healthcare services companies to improve health outcomes and broaden access while lowering costs of care. We partner with inspirational entrepreneurs who seek to transform the business of healthcare by developing innovative and impactful products and services. Flare Capital is a team of proven healthcare technology investors and senior operating executives known for thought leadership and unparalleled strategic industry resources. Our firm has raised some of the industry’s largest dedicated venture capital funds focused on early-stage opportunities in healthcare technology innovation, and our investors include leading healthcare companies, major institutional investors, important family offices, foundations, and sovereign wealth funds. We are full life-cycle investors in our portfolio companies as we work alongside entrepreneurs over their entire company-building journey. Select portfolio companies include Aetion, Aspen RxHealth, Bright Heath, Cayaba Care, Cohere Health, Eden Health, HealthVerity, Inbound Health, Iora Health, Oshi Health, Somatus, and VisitPay. The firm has developed the very successful Flare Scholar program with over 250 participants and actively leverages its extended industry network, Executive Partners, and Industry Advisory Board for the benefit of the entrepreneurs and founders with whom it is privileged to partner.

Read More

HEALTHTECH SECURITY,FUTURE OF HEALTHCARE

Sightpath Medical Acquires Accusite Surgical

Sightpath Medical | November 22, 2022

Sightpath Medical, the leading provider of mobile ophthalmic services for cataract and refractive surgery, announced that it has acquired Accusite Surgical, a cataract surgery equipment outsourcing company. Founded in 1991, Sightpath Medical delivers custom access to advanced ophthalmic equipment, instruments, and services to facilities and surgeons across the United States. Through its patented technology, the company was the first to mobilize phacoemulsification machines, excimer lasers, the IntraLase Femtosecond Laser, and the LenSx Femtosecond Laser. Sightpath Medical has earned the trust of medical professionals and patients nationwide through the quality of its equipment, the skill of its employees, and the dedication and responsiveness of its staff. Accusite Surgical is a mobile cataract surgical company that outsources state-of-the-art equipment, technology, and certified staff to surgeons, ambulatory surgical centers, and hospitals. For over 28 years, the company has assisted in more than 200,000 procedures throughout the Southeastern U.S. In connection with the transaction, D. Lynn Godfrey, Founder and Chief Executive Officer of Accusite Surgical, will join Sightpath Medical as Chief Strategy Officer. “This strategic combination bolsters Sightpath Medical’s market-leading position and enhances our ability to deliver variable, tailored access to the expert personnel, equipment, and supplies surgeons need to provide critical eye care. We are delighted to begin integrating the Accusite Surgical business into ours and are equally excited to welcome Lynn Godfrey, who is an experienced and creative executive, to our management team. We look forward to growing Sightpath Medical together.” Joel Gaslin, President and CEO of Sightpath Medical Mr. Godfrey added, “After 28 years, I began exploring the long-term options for my business and quickly determined that the Sightpath Medical executive team and its financial partner, MGG Investment Group, were the right partners for Accusite Surgical. We are closely aligned on our core mission of helping surgeons and their referring Optometrists provide patients with excellent eye care and, ultimately, better vision. I am thrilled to commence Accusite Surgical’s next chapter as part of Sightpath Medical.” About Sightpath Medical Sightpath Medical is the leading U.S. provider of mobile ophthalmic services for cataract, refractive and laser-assisted surgery. Working alongside more than 1,200 surgeons and the staffs of their surgical facilities for more than 30 years, Sightpath Medical is the market-leading choice for surgeons, ASCs, and hospitals due to our proven ability to deliver the staff, equipment, and supplies wherever and whenever they are needed – regardless of geography. About Accusite Surgical For nearly three decades, Accusite Surgical has been a leading provider of state-of-the-art equipment, supplies, and support for cataract surgery in the Southeastern United States. Accusite Surgical is a trusted partner to ASCs and hospitals and ophthalmologists for cataract surgery services and is committed to helping surgeons grow their practices while delivering superior outcomes for patients.

Read More